Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 13, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kumaraguru Raja Initiated (ADIL) at Strong Buy and Held Target at $300 on, Oct 13th, 2021
Kumaraguru Raja of Brookline Capital, Initiated "Adial Pharmaceuticals, Inc." (ADIL) at Strong Buy and Held Target at $300 on, Oct 13th, 2021.
Kumaraguru has made no other calls on ADIL in the last 4 months.
There is 1 other peer that has a rating on ADIL. Out of the 1 peers that are also analyzing ADIL, 0 agree with Kumaraguru's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kumaraguru
- Theodore O'Neill of "Litchfield Hills" Initiated at Strong Buy and Held Target at $125 on, Tuesday, June 29th, 2021
